Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Prophylactic ICD Cost Considerations: Will They Upstage MCAC Data Review?

Related Content

Guidant MADIT II Trial Could Support Doubling Of ICD-Eligible Population

Nov 26 2001

ICD Guidelines From ACC/AHA/NASPE Embrace MADIT-II Prophylactic Use

Sep 30 2002

CMS Coverage Guidance: Reasonable/Necessary Not Defined, But Approached

Oct 28 2002

More from Archive

More from Medtech Insight

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window